Lifecore Biomedical, Inc. LFCR
4.20
(0.09)
(2.10%)
as of 25 Sep
- Market cap
- $162.4M
- P/E
- 0.0×
Follow LFCR
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(1,055.37%) | 0.00% | 293.76% | 201.15% | |
| (22.04%) | 0.00% | (35.31%) | (19.32%) | ||
ROIC |
(3.95%) | 0.00% | (2.32%) | (2.80%) | |
Return on Tangible Assets |
(14.20%) | 0.00% | (21.79%) | (24.16%) | |
Average Days of Receivables |
72.37 | 0.00 | 58.22 | 92.96 | |
Free Cash Flow per Share |
0.35 | — | 0.36 | (0.13) | |
Free Cash Flow |
13.17 | — | 13.50 | (5.06) | |
Capital Expenditures |
(1.25) | — | (0.27) | (4.55) | |
Piotroski F-Score |
4.00 | — | 4.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
6.67% | 0.00% | 7.28% | (0.23%) | |
Accounts Receivable Turnover |
4.53 | 0.00 | 5.06 | 4.33 | |
Accounts Payable Turnover |
6.90 | 0.00 | 11.53 | 9.91 | |
Inventory Turnover |
2.37 | 0.00 | 2.91 | 2.95 | |
Average Days of Payables |
42.64 | 0.00 | 29.15 | 31.44 | |
Days of Inventory on Hand |
142.50 | 0.00 | 117.01 | 106.32 | |
Tax Rate |
0.03 | — | 0.02 | 0.02 | |
Research and Development Expense of Revenue |
6.51% | — | 5.95% | 5.59% | |
Selling, General and Administrative Expense of Revenue |
34.42% | — | 28.47% | 28.16% | |
Share Based Compensation of Revenue |
(1.40%) | — | (1.53%) | 3.51% | |
Interest Coverage |
0.00 | — | 0.00 | 0.00 | |
Operating CF/Net income |
(0.56) | — | (0.35) | 0.01 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.04 | |
Capex/Depreciation |
5.29 | — | (1.72) | (0.95) | |
Revenue per Share |
3.34 | — | 3.25 | 3.18 | |
Operating CF per Share |
0.39 | — | 0.37 | (0.01) | |
Capex per Share |
(0.03) | — | (0.01) | (0.12) | |
Capex to Sales |
0.01 | — | 0.00 | 0.04 | |
Net Profit Margin |
(20.77%) | — | (32.67%) | (37.54%) |
Columns are period end dates